Clinical Trials Browser

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

NCT00006002 2013-09-05

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

36 enrolled

Genitourinary

Prostatic Neoplasms

NCT00006013 2013-07-11

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Phase 2 Completed

21 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00026260 2013-06-24

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

Gynecologic

Uterine Cervical Neoplasms

NCT00006001 2013-06-03

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Phase 2 Terminated

37 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00006014 2013-06-03

SU5416 in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

45 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00005862 2013-02-11

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Phase 2 Completed

60 enrolled

GastrointestinalSarcoma

Sarcoma, Gastrointestinal Stromal Tumors

NCT00017316 2013-02-11

Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma

Phase 2 Completed

35 enrolled

Dermatologic

Melanoma

NCT00006003 2013-01-24

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

Phase 2 Terminated

35 enrolled

Dermatologic

Melanoma

NCT00009919 2013-01-23

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

Phase 2 Terminated

50 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00006384 2011-10-20

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 2 Completed

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00006361 2009-12-04

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Phase 2 Completed

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Skin Neoplasms

NCT00005931 2005-06-24

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

Phase 2 Completed

30 enrolled

DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Clinical Trials

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

SU5416 in Treating Patients With Malignant Mesothelioma

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment

SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment